Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

SEC Form 8-K: Press Release dated August 24, 2021

Download

SEC Form 424B5: PROSPECTUS SUPPLEMENT (To Prospectus dated June 5, 2019)

Download

SEC Form 8-K: Items 8.01 & 9.01

Download

SEC Form 8K: Press Release Dated August 13, 2021

Download

SEC Form 10-Q for period ending June 30, 2021

Download

SEC Form 8K: Press Release Dated June 22, 2021

Download

SEC Form 8K: Press Release Dated May 14, 2021

Download

SEC Form 10-Q for period ending March 31, 2021

Download

Interactive Data 10-Q

Download Files

SEC Form 8K: Press Release Dated April 22, 2021

Download

Bio-Path Holdings

All Rights Reserved

Office:

625 Stanwix Street
Pittsburgh, PA, 15222

T: (630) 708-0750

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us